Carotech Completes FDA’s GMP Inspection


Carotech's Malaysia production facility receives a visit from FDA.

Palm tocotrienol supplier Carotech Inc. (Edison, NJ) reports that its Malaysia production facility recently underwent an FDA inspection for GMPs.

“We are very pleased to have our facility inspected by the FDA for GMP compliance,” said Carotech vice president WH Leong. “This is another milestone for us in conformance to the GMP system, as well as quality commitment to our customers. Carotech has always followed stringent GMP manufacturing guidelines to ensure our products are of the best quality, consistency, and have the purity and safety that meet our customers’ product development requirements, because they, too, are subjected to FDA GMP inspection.”

Recent Videos
Nils Hoem and Nutritional Outlook editor Sebastian Krawiec
Related Content
© 2024 MJH Life Sciences

All rights reserved.